AZD5148

Monoclonal antibody

Automated registry profile: compiled from public clinical-trial and regulatory records; not yet individually analyst-verified.

Earlyevidence

Evidence outlook

Early-stage evidence only

Phase 1 / first-in-human studies establish safety, tolerability, and dosing; they are not designed to demonstrate efficacy, so no evidence signal is assigned yet. The first graded signal arrives with a completed confirmatory readout.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 2 (1)
Other / comorbidity
NCT07285213 · AstraZeneca
2025-12-10 – 2028-01-18 · Clostridioides Difficile Infection
What this study did
Phase 1 (2)
Other / comorbidity
NCT06639997 · AstraZeneca
2024-10-31 – 2025-12-25 · Clostridioides Difficile Infection
What this study did
NCT06469151 · AstraZeneca
2024-06-24 – 2025-10-22 · Healthy Participants
What this study did

Competitive landscape

This drug's own stage for Recurrent Clostridioides Difficile Infection: Stage not on record. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
AZD5148: this drugStage not on recordMonoclonal antibodyClostridioides difficile toxin B (TcdB)not yet gradedNo reviewed efficacy summary in this indication
Fecal Microbiota Spores, Live-Brpk (VOWST)ApprovedMicrobiome therapeutic—Weak signalNo reviewed efficacy summary in this indication

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow AZD5148 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
April 2027 (1)
Phase 2Clostridioides Difficile InfectionRecruiting
Est. primary completion 2027-04-20 · NCT07285213 · CT.gov ↗
What to watch

See the full readout calendar ↗